Aztiq sells Adalvo to EQT
3 Articles
3 Articles
Aztiq sells Adalvo to EQT
Adalvo was founded in 2018 by Aztiq and is one of the leading business-to-business pharmaceutical companies in EuropeEQT will support Adalvo’s next phase of growth, expanding its geographic footprint, and advancing the operational scale-up of the businessAztiq will remain a…
Investment firm Aztiq, majority-owned by Robert Wessman, has completed the sale of almost all of its stake in Adalvo to international investment giant EQT, valuing the pharmaceutical company at around $1 billion in the deal. Robert says that with the sale, he is trying to "simplify his life" so that he can devote all his time to the operation of Alvotech, while he is also working to complete the sale of the generic drug company Alvogen in the Un…
Coverage Details
Bias Distribution
- 100% of the sources lean Left
Factuality
To view factuality data please Upgrade to Premium